Timothy Churchill is a Cardiology physician affiliated with Boston Biomedical Research Institute. OpenAlex indexes 157 publications with 2,484 citations (h-index 27).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit St
Boston, MA 021142621
Telephone
617-726-2677Registry record last updated 22 Mar 2018.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ACADIA Pharmaceuticals IncProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.7%Statin26%Rosuvastatin Calcium64%Atorvastatin Calcium36%Part D≥20 patientsBeta blocker19%Metoprolol Succinate67%Carvedilol33%Part D<11 patients+ 6 more classes in this area
Blood & clotting
9.7%Factor Xa inhibitor9.7%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
3.7%SGLT2 inhibitor3.7%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2022–2025 per NIH RePORTER. The latest:
- Aortic Dilatation in Endurance Athletes: A Physiologic and Mechanistic Study
Massachusetts General Hospital
FY2025$196,560K23HL159262 - Aortic Dilatation in Endurance Athletes: A Physiologic and Mechanistic Study
Massachusetts General Hospital
FY2024$196,560K23HL159262 - Aortic Dilatation in Endurance Athletes: A Physiologic and Mechanistic Study
Massachusetts General Hospital
FY2023$196,560K23HL159262
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities
Journal of the American College of Cardiology
2025 - Survival Outcomes After Sudden Cardiac Arrest in Young Competitive Athletes From the United States
Journal of the American College of Cardiology
2025 - Accelerometer-Measured Sedentary Behavior and Risk of Future Cardiovascular Disease
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”